Your browser doesn't support javascript.
loading
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
Chow, Clara K; Thakkar, Jay; Bennett, Alex; Hillis, Graham; Burke, Michael; Usherwood, Tim; Vo, Kha; Rogers, Kris; Atkins, Emily; Webster, Ruth; Chou, Michael; Dehbi, Hakim-Moulay; Salam, Abdul; Patel, Anushka; Neal, Bruce; Peiris, David; Krum, Henry; Chalmers, John; Nelson, Mark; Reid, Christopher M; Woodward, Mark; Hilmer, Sarah; Thom, Simon; Rodgers, Anthony.
Affiliation
  • Chow CK; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia; Westmead Hospital, Sydney, NSW, Australia; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia. Electronic address: cchow@georgeinstitute.org.au.
  • Thakkar J; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia; Westmead Hospital, Sydney, NSW, Australia.
  • Bennett A; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
  • Hillis G; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia; The University of Western Australia, Perth, WA, Australia.
  • Burke M; Kildare Road Medical Centre, Sydney, NSW, Australia.
  • Usherwood T; The University of Sydney, Sydney, NSW, Australia.
  • Vo K; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
  • Rogers K; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
  • Atkins E; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
  • Webster R; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
  • Chou M; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Dehbi HM; Imperial College, London, UK.
  • Salam A; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
  • Patel A; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Neal B; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia; Imperial College, London, UK; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Peiris D; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
  • Krum H; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic, Australia.
  • Chalmers J; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
  • Nelson M; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tas, Australia.
  • Reid CM; Curtin University, Perth, WA, Australia.
  • Woodward M; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
  • Hilmer S; The University of Sydney, Sydney, NSW, Australia.
  • Thom S; Imperial College, London, UK.
  • Rodgers A; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia.
Lancet ; 389(10073): 1035-1042, 2017 03 11.
Article in En | MEDLINE | ID: mdl-28190578
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article